Lone atrial fibrillation: more than meets the eye.
Doxorubicin has been used as a chemotherapeutic agent for over 30 years. Its cardiac toxicity has been known for over 20 years. In recent years, delayed-onset cardiac toxicity has been described as yet another cardiac complication of doxorubicin and other anthracyclines. The following case is felt to represent such an example.